机译:候选凋亡和DNA修复基因方法证实ERCC1,ERCC5,TP53和MDM2参与头部和颈部癌症的辐射诱导的毒性
Antoine Lacassagne Canc Ctr Dept Oncol Nice France;
Antoine Lacassagne Canc Ctr Oncopharmacol Unit Nice France;
Ctr Haute Energie Nice France;
Antoine Lacassagne Canc Ctr Dept Radiotherapy Nice France;
Acad Inst Head &
Neck Canc Nice France;
Acad Inst Head &
Neck Canc Nice France;
Antoine Lacassagne Canc Ctr Oncopharmacol Unit Nice France;
Antoine Lacassagne Canc Ctr Oncopharmacol Unit Nice France;
Antoine Lacassagne Canc Ctr Oncopharmacol Unit Nice France;
Antoine Lacassagne Canc Ctr Epidemiol &
Biostat Unit Nice France;
Antoine Lacassagne Canc Ctr Dept Radiotherapy Nice France;
Antoine Lacassagne Canc Ctr Oncopharmacol Unit Nice France;
机译:候选凋亡和DNA修复基因方法证实ERCC1,ERCC5,TP53和MDM2参与头部和颈部癌症的辐射诱导的毒性
机译:头颈部鳞状细胞癌的DNA修复基因切除修复交叉互补组1(ERCC1):甲基化和多态性(G19007A),蛋白质表达分析以及与流行病学和临床病理因素的关联
机译:喉癌修复途径基因ERCC1,ERCC2,ERCC3,ERCC4,ERCC5和XPA中的喉癌风险和常见的单核苷酸多态性
机译:FasL基因疗法和酸性神经酰胺酶抑制剂的组合:一种治疗头颈癌的新型治疗方法。
机译:定量切除修复交叉互补组1(ERCC1)和p16阴性鳞状上皮性头颈癌的存活率
机译:DNA修复基因ERCC1和ERCC2 / XPD多态性以及头部和颈部鳞状细胞癌的风险